Multiple Myeloma in Russia (First Results of the Registration Trial)
Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), И Г Рехтина, Olga Dianova, С В Беляева, A. M. Alexeeva, Natalia Mashnina, M.N. Shirokova, Svetlana Osjnihina, В. С. Богова, Д. А. Морозов, Ekaterina Lisina, Islam Nakastoev, Imisa Baygishieva, Elena Voronova, Elena Patrakova, Irina Verkhoglyad, Zhanna Davydova(Kharkiv National Medical University), Kamil Kaplanov(Volgograd Regional Clinical Oncology Center), Ochsana Ochirova, Т. С. Капорская, Valery Lapin, M. G. Kiseleva, Natalia Esefyeva, Ekaterina Krupkina, Guzaliya Gaynullina, Naida Baygishieva, Yana Tsinchenko, Elena Volodicheva, Е. Н. Зотина, Tatiana Shelekhova, Yury Dunaev, Е. Г. Кириллова, Elena Borisenkova(Murmansk Regional Clinical Hospital), Marina Kosinova, Valentine Molostvova, S. G. Menshikova, И. Л. Давыдкин(Samara State Medical University), М. А. Михалев, Е О Грибанова, М. А. Новикова, Т. С. Константинова(Regional Children's Clinical Hospital No. 1), Maxim Solovev(National Medical Research Center for Hematology), Olga Samoilova, Natalya Popova, Marina Kozmina, Т. А. Гриценко, Anna V. Zarubina, Ekaterina Kalinovskay, Natalia Rachkova, Elena Kuznetcova
Cited by 5
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
|The Lancet Oncology|2020|70
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59